InfuSystems Holdings, Inc.

Stage 2 · Advancing · week 11

As of Oct 22, 2026, InfuSystems Holdings is in Stage 2, the uptrend phase, now in week 11 (since Aug 6, 2026). It closed at $14.14, 0.6% below its 52-week high and above its 200-day average, which is rising.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. More about the company

$14.14

+1.00% today

$282M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care

Is INFU early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 33w

S3 17w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 7w → S3 10w → S2 10w → S3 1w → S4 33w → S1 6w → S2 10w → S3 6w → S4 10w → S1 11w → S2 12w → S3 17w → S2 11w → S3 6w → S4 1w → S3 1w → S2 11w current

Total tracked: 165 weeks across 17 stage runs.

INFU among Medical Devices16th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…16	INFUInfuSystems Holdings, Inc.	Stage 2 · wk 11	85	+11.3%

vs 52W High

-0.6%

$7.42 lo$14.23 hi

Near 52W high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 11

1w13w26w

Week 11, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

39.1%

200 DMA: $10.17 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

1.02x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↑

Short-term trend rising strongly

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+11.3%

+55.0%

+37.7%

YTD

+68.5%

+46.1%

Scan Membership

Breakout Watch

Latest: 2024-12-02

11 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 11 · Vol 1.02x

2026-10-21S2

Wk 11 · Vol 1.24x

2026-10-20S2

Wk 11 · Vol 0.97x

2026-10-19S2

Wk 11 · Vol 0.80x

2026-10-16S2

Wk 11 · Vol 1.07x

2026-10-15S2

Wk 10 · Vol 0.68x

2026-10-14S2

Wk 10 · Vol 1.02x

2026-10-13S2

Wk 10 · Vol 0.73x

2026-10-12S2

Wk 10 · Vol 0.81x

2026-10-09S2

Wk 10 · Vol 0.44x

2026-10-08S2

Wk 9 · Vol 0.65x

2026-10-07S2

Wk 9 · Vol 0.78x

Moving averages & range

50 DMA

$12.75

200 DMA

$10.17

52W High

$14.23

52W Low

$7.42

5D Low

$13.40

Resistance levels (recent highs)

20d High

$14.23

60d High

$14.23

120d High

$14.23

250d High

$14.23

Next resistance

+0.6%

to 20d High

P/E (TTM)

35.4

Forward 27.2

Earnings Growth (YoY)

+25.0%

Revenue +2.6%

ROE

+15.0%

Profit margin +6.0%

Dividend Yield

0.00%

P/B 4.8

InfuSystems Holdings: quick answers

What stage is InfuSystems Holdings in?

As of Oct 22, 2026, InfuSystems Holdings (INFU) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 6, 2026 and is in week 11. What the four stages mean

Is InfuSystems Holdings in an uptrend?

Yes. InfuSystems Holdings is in a Stage 2 uptrend. It trades 39.1% above its 200-day average, which is rising.

How far is InfuSystems Holdings from its 52-week high?

InfuSystems Holdings closed at $14.14 on Oct 22, 2026, 0.6% below its 52-week high of $14.23. Its 52-week low is $7.42.

How has InfuSystems Holdings performed over the past year?

As of Oct 22, 2026, InfuSystems Holdings is up 46.1% over the past year and up 68.5% so far in 2026.

Which sector and industry is InfuSystems Holdings in?

InfuSystems Holdings is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.